Physician profile
Michelle Ranes
NPI 1689994964
$2,953.06
in general payments reported to CMS, 2019-2025
43 companies · $541 in 2025
The $541 reported for 2025 was more than what 82% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $70.09 · 2021: $366 · 2022: $776 · 2023: $471 · 2024: $410 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $305.14 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $259.81 | 2021-2025 | |
| Hologic Sales and Service, LLC | $238.37 | 2021-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Abbvie INC. | $220.43 | 2019-2025 | |
| Gynesonics, INC. | $197.66 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $173.31 | 2021-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $136.64 | 2020-2024 | |
| Organon LLC | $113.19 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $103.86 | 2021-2022 | |
| Dysis Medical, INC. | $91.67 | 2019 | |
| Coopersurgical, INC. | $84.86 | 2020-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Sumitomo Pharma America, INC. | $78.36 | 2023-2025 | Myfembree |
| Pfizer INC. | $76.12 | 2022-2024 | |
| Smith+Nephew, INC. | $65.00 | 2022-2024 | Pico |
| Amag Pharmaceuticals, INC. | $61.83 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ranes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.